awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42730901-432AF95F-F8ED-479A-AA61-EE45E6C62BE1
Q42730901-432AF95F-F8ED-479A-AA61-EE45E6C62BE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42730901-432AF95F-F8ED-479A-AA61-EE45E6C62BE1
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors.
P2860
Q42730901-432AF95F-F8ED-479A-AA61-EE45E6C62BE1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42730901-432AF95F-F8ED-479A-AA61-EE45E6C62BE1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
450134c222f3c2f40f077b13f2e048a5e96a0e07
P2860
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.